What one share of Sonoma Pharmaceuticals holds
Inc. in 1999 under the laws of the State of California. We changed our name to Oculus Innovative Sciences, Inc. in 2001. In December 2006
Sonoma Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $9.81 |
|---|---|
| Profit | −$1.01 |
| Capex (buildings and equipment) | $0.04 |
| Free cash flow | −$1.19 |
| Cash and investments | $1.12 |
| Book value | $1.38 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | $27.99 | −$10.63 | $0.00 | −$5.27 | — | $7.86 |
| 2025 | $11.51 | −$2.79 | $0.06 | −$0.14 | — | $2.70 |
| 2026 | $11.60 | −$1.89 | $0.11 | −$2.45 | — | $1.72 |
Common questions about Sonoma Pharmaceuticals
How much does one share of Sonoma Pharmaceuticals earn?
Over the last 12 months, Sonoma Pharmaceuticals lost $1.01 for each share on $9.81 of sales.
Does Sonoma Pharmaceuticals pay a dividend?
Sonoma Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Sonoma Pharmaceuticals’s book value per share?
Sonoma Pharmaceuticals’s book value is $1.38 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Sonoma Pharmaceuticals have?
Each share of Sonoma Pharmaceuticals has $1.12 of cash and investments, as of June 30, 2026.
What is Sonoma Pharmaceuticals’s free cash flow per share?
−$1.19 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.